These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33057916)

  • 41. Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy.
    Tanaka K; Mori R; Kawamura A; Nakashizuka H; Wakatsuki Y; Yuzawa M
    Br J Ophthalmol; 2017 Jan; 101(1):51-55. PubMed ID: 27913447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lateral elongation of flat irregular pigment epithelial detachment: A novel optical coherence tomography biomarker in polypoidal choroidal vasculopathy.
    Alex D; Giridhar A; Gopalakrishnan M; Indu VP
    Indian J Ophthalmol; 2020 Jan; 68(1):134-140. PubMed ID: 31856491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of polypoidal choroidal vasculopathy studied by colocalization between tomographic and angiographic lesions.
    Kim JH; Kang SW; Kim TH; Kim SJ; Ahn J
    Am J Ophthalmol; 2013 Nov; 156(5):974-980.e2. PubMed ID: 23958701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.
    Lee CS; Woo SJ; Kim YK; Hwang DJ; Kang HM; Kim H; Lee SC
    Ophthalmology; 2014 May; 121(5):1029-35. PubMed ID: 24439757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DISTINGUISHING POLYPOIDAL CHOROIDAL VASCULOPATHY FROM TYPICAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION BASED ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Liu R; Li J; Li Z; Yu S; Yang Y; Yan H; Zeng J; Tang S; Ding X
    Retina; 2016 Apr; 36(4):778-86. PubMed ID: 26428604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy.
    Takayama K; Ito Y; Kaneko H; Kataoka K; Sugita T; Maruko R; Hattori K; Ra E; Haga F; Terasaki H
    Eye (Lond); 2017 Jan; 31(1):45-52. PubMed ID: 27813526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy.
    Jeong A; Lim J; Sagong M
    Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):29. PubMed ID: 33605985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration.
    Chaikitmongkol V; Ozimek M; Srisomboon T; Patikulsila D; Fraser-Bell S; Chhablani J; Choovuthayakorn J; Watanachai N; Kunavisarut P; Rodríguez-Valdés PJ; Lozano-Rechy D; Lupidi M; Al-Sheikh M; Fung AT; Busch C; Mehta H; Gabrielle PH; Zur D; Ramon D; Sangkaew A; Ingviya T; Amphornprut A; Cebeci Z; Couturier A; Mendes TS; Giancipoli E; Iglicki M; Invernizzi A; Lains I; Rehak M; Sala-Puigdollers A; Okada M; Loewenstein A; Bressler NM
    Am J Ophthalmol; 2022 Dec; 244():58-67. PubMed ID: 35952753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium.
    Kumar S; Berriochoa Z; Ambati BK; Fu Y
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3842-50. PubMed ID: 24854852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy.
    Yang LH; Jonas JB; Wei WB
    Retina; 2013 Sep; 33(8):1584-9. PubMed ID: 23584691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Clinical Findings, Optical Coherence Tomography, Fundus Fluorescein Angiography, and Indocyanine Green Angiography Imaging in Patients with Polypoidal Choroidal Vasculopathy.
    Garip R; Yasa D; Ozkaya A
    Beyoglu Eye J; 2020; 5(2):135-141. PubMed ID: 35098077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration.
    Coscas G; Lupidi M; Coscas F; Benjelloun F; Zerbib J; Dirani A; Semoun O; Souied EH
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3187-95. PubMed ID: 26024102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SENSITIVITY AND SPECIFICITY OF DETECTING POLYPOIDAL CHOROIDAL VASCULOPATHY WITH EN FACE OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    de Carlo TE; Kokame GT; Kaneko KN; Lian R; Lai JC; Wee R
    Retina; 2019 Jul; 39(7):1343-1352. PubMed ID: 29561386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Park SJ; Kim BH; Park KH; Woo SJ
    Am J Ophthalmol; 2014 Dec; 158(6):1155-1163.e1. PubMed ID: 25127698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy.
    Zhan Z; Sun L; Jin C; Yang Y; Hu A; Tang M; Wang Z; Ding X
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2349-2356. PubMed ID: 31446460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-Related Scattered Hypofluorescent Spots on Late-Phase Indocyanine Green Angiography as Precursor Lesions of Polypoidal Choroidal Vasculopathy.
    Chen L; Zhang X; Li M; Liao N; Wen F
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2102-2109. PubMed ID: 31095678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic evaluation of type 2 (classic) choroidal neovascularization: optical coherence tomography, indocyanine green angiography, and fluorescein angiography.
    Sulzbacher F; Kiss C; Munk M; Deak G; Sacu S; Schmidt-Erfurth U
    Am J Ophthalmol; 2011 Nov; 152(5):799-806.e1. PubMed ID: 21742302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study.
    Tan CS; Ngo WK; Lim LW; Tan NW; Lim TH;
    Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1923-1930. PubMed ID: 27142805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral and macular polypoidal choroidal vasculopathy: A retrospective comparative case series.
    Venkatesh R; Mishra P; Nahata H; Reddy NG; Yadav NK; Chhablani J
    Eur J Ophthalmol; 2023 Jan; 33(1):448-454. PubMed ID: 35535409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy.
    Saito M; Iida T; Nagayama D
    Retina; 2008 Mar; 28(3):459-64. PubMed ID: 18327139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.